Urine test shows promise for diagnosing urothelial carcinomaAugust 30, 2023OncologyGenitourinary Cancer
New trials in prostate cancer: Could your patient benefit?August 25, 2023Genitourinary CancerProstate Cancer
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancerAugust 14, 2023Genitourinary CancerProstate Cancer
How useful are circulating tumor cells for early diagnosis?August 9, 2023Breast CancerLung CancerGenitourinary Cancer
MRI-guided SBRT cuts radiation toxicity in prostate cancerJuly 26, 2023Genitourinary CancerProstate Cancer
‘Treatment holiday’ in prostate cancer with tailored dosingJuly 25, 2023Genitourinary CancerProstate Cancer
Cancer Patients: Who’s at Risk for Venous Thromboembolism?July 24, 2023Hematologic MalignanciesWomen's HealthGenitourinary Cancer
No benefit to adding limited radiation in advanced cancerJuly 11, 2023Lung CancerMelanomaGenitourinary Cancer
Cancer Data Trends 2023July 5, 2023CancerBreast CancerGenitourinary CancerLung CancerProstate CancerColon and RectalNeurology
Promising New Approaches for Testicular and Prostate CancerJuly 5, 2023Prostate CancerGenitourinary CancerCancer
Multiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicineBreast CancerGenitourinary CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
